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Abstract
Metabolomics is a rapidly growing field consisting of the analysis of a large number of metabolites at a system scale. The
two major goals of metabolomics are the identification of the metabolites characterizing each organism state and the
measurement of their dynamics under different situations (e.g. pathological conditions, environmental factors). Knowledge
about metabolites is crucial for the understanding of most cellular phenomena, but this information alone is not sufficient
to gain a comprehensive view of all the biological processes involved. Integrated approaches combining metabolomics with
transcriptomics and proteomics are thus required to obtain much deeper insights than any of these techniques alone.
Although this information is available, multilevel integration of different ‘omics’ data is still a challenge. The handling,
processing, analysis and integration of these data require specialized mathematical, statistical and bioinformatics tools,
and several technical problems hampering a rapid progress in the field exist. Here, we review four main tools for number of
users or provided features (MetaCoreTM, MetaboAnalyst, InCroMAP and 3Omics) out of the several available for metabolomic
data analysis and integration with other ‘omics’ data, highlighting their strong and weak aspects; a number of related issues
affecting data analysis and integration are also identified and discussed. Overall, we provide an objective description of how
some of the main currently available software packages work, which may help the experimental practitioner in the choice
of a robust pipeline for metabolomic data analysis and integration.
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Introduction
Metabolomics is an emerging field of the biological sciences; it
concerns the high-throughput characterization of metabolites,
i.e. small molecular compounds (< 1500 Da), which constitute
the end products of the cellular metabolism and form the chem-
ical fingerprint of an organism at a precise time point. More pre-
cisely, metabolomic studies involve the identification and
quantification of metabolites, with the aim of correlating their
changes with pathological states, or with the effect of external
influencing factors such as drugs or contaminants [1]. Together
with the other main ‘omics’ areas (genomics, transcriptomics
and proteomics), metabolomics constitutes one of the building
blocks of systems biology. Because of its focus on small mol-
ecules and small interactions, it has lately reached a wide-
spread application in many different fields, including molecular
epidemiology, toxicity assessment, functional and nutritional
genomics, biomarker discovery and identification, drug devel-
opment and personalized health care [1–3].
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The following two are the general analytical approaches in
performing a metabolomic analysis: targeted and untargeted.
Targeted metabolomics refers to the detection and precise quan-
tification (in nM, or mg/mL) of a small set of known compounds.
It is driven by a specific biochemical question or hypothesis in
which the set of metabolites related to one or more pathways is
already defined. A limitation of the targeted approach is that it
requires the compounds of interest to be known a priori, and to
be available in their purified form. Currently, only few purified
standards (i.e. defined groups of chemically characterized and
biochemically annotated metabolites) have been clearly identi-
fied and are available for a calibration process; therefore, owing
to the wide variety of metabolites and their complex dynamics
within a cell, the targeted approach cannot yet be used alone for
a comprehensive analysis of the metabolome. The untargeted
approach instead, also called ‘metabolite fingerprinting’, is not
driven by an a priori hypothesis and it is used for complete
metabolome comparison (i.e. as many metabolites as possible
are measured and compared between samples) [4]. Metabolite
variations are observed principally as total changes of chroma-
tographic patterns without requiring previous knowledge of the
compounds under investigation. Therefore, untargeted metabo-
lomics does not attempt to precisely quantify all measurable
metabolites in a sample, but it only gives their relative quantifi-
cation (fold change) [5, 6]. It is important to stress that, in spite
of the presence of extensive metabolomics spectra repositories
(e.g. SMPDB [7], KEEG [8], MetaCyc [9] and HumanCyc [10] to cite
some), metabolite identification still constitutes a challenge in
untargeted metabolomics. This is mainly because of techno-
logical limitations such as the dependence on the intrinsic ana-
lytical coverage of the platform used, and the possible bias
toward the detection of the most abundant molecules [11].
Moreover, the same molecule can be fragmented differently de-
pending on the specific instrument or technique used, and this
hampers the metabolites spectra matching. Furthermore, in-
strument-dependent variability between different kinds of
mass-analyzers and even between the ones of the same kind,
but of different brands, increases the variability in compound
identification.
Metabolomic research leads to the handling of complex data
sets, which include hundreds of metabolites; their comprehen-
sive evaluation requires a specialized data analysis that in-
volves cheminformatics, bioinformatics and statistics aspects.
Moreover, to better understand the role of each metabolite in
the studied condition, metabolomic data must be interpreted;
this requires that every chemical information derived from
metabolomic analyses has to be related to both biochemical
causes and physiological consequences [1, 12]. Toward this end,
the multilevel integration of metabolomic, proteomic and tran-
scriptomic information is fundamental for a better understand-
ing of the cellular biology. Although this information is
available, its fast evaluation and integration is still hampered
by technical and biological issues, including (i) the complexity
and heterogeneity intrinsic to biological data, which require ap-
propriate statistical and computational analysis methods; (ii)
the limited reproducibility of the results of transcriptomic,
proteomic and metabolomic research and the heterogeneity of
the available analysis techniques, which make data comparison
among different labs hard; (iii) the lack of standard data formats
both for ‘omics’ data and for metadata; and (iv) the need of
user-friendly tools for integrative analysis of multiple data
types [13, 14].
Although several literature about metabolomic data produc-
tion and analysis techniques exist [3–5, 15–23], to the best of our
knowledge, a comprehensive review illustrating the available
tools for the analysis and integration of metabolomic data with
other ‘omics’ data has not been reported yet. Here, we describe
and compare four tools (MetaCoreTM, MetaboAnalyst, InCroMAP
and 3Omics [24–27]), which we selected among the several ones
currently available for metabolomic data analysis and integra-
tion (Table 1 reports a list of the tools most frequently cited in
the literature); related issues and challenges arising in ‘omics’
data integration and analysis are also identified and discussed.
MetaCoreTM and MetaboAnalyst are the most commonly
used tools by researchers who work with metabolomic data (the
number of data analysis jobs submitted to MetaboAnalyst was
about 40 000/month in 2014 [41]). Both of them have been avail-
able since several years (since 2004 and 2009, respectively).
Conversely, InCroMAP and 3Omics have been implemented
more recently (in 2011 and 2013, respectively), and they have
not yet overcome the previous ones. However, given their ease
of use, the knowledge of these two latter tools may be advanta-
geous for researchers interested in evaluating the current possi-
bility to integrate ‘omics’ data across multiple platforms. In this
review, we provide an objective and practical assessment of
these tools, which may be helpful as a guide for the choice of a
robust pipeline for metabolomic data integration and analysis.
We do not give a description of ‘the best tools’ for metabolomic
data analysis, but we elucidate how some of the main currently
available software packages work, highlighting their strong and
weak aspects.
Metabolomic analysis workflow: a brief
overview
A detailed description of how a metabolomic analysis is per-
formed can be found in [5, 6, 15]. In the following, we provide a
brief overview to better understand the related issues; we sum-
marize the main aspects, focusing on the integration with other
kinds of ‘omics’ data.
A typical metabolomic study consists of several different
parts (schematized in Figure 1), which can be grouped in four
main steps [5, 12, 16, 42].
Sample preparation
The first step in the metabolomic workflow is the preparation of
the biological sample (e.g. blood plasma and serum, urine, sal-
iva, solid tissues and cultured cells). According to the kind of
sample to analyze, several approaches are used, as described in
details elsewhere [18–21]. Samples are usually homogenized or
pulverized into smaller particles to increase their surface area
for the exposure to the extraction buffer, which is chosen in ac-
cordance to their chemical characteristics.
Data acquisition
Once the sample is ready, different techniques can be used to
separate and characterize chemically diverse groups of metab-
olites. To have different measurement dimensions based both
on chemical and physical properties of metabolites, compound
separation techniques (e.g. gas chromatography, high-perform-
ance liquid chromatography, ultra-high-performance liquid
chromatography and capillary electrophoresis) are combined
with compound detection techniques, such as mass spectrom-
etry (MS) or nuclear magnetic resonance (NMR). Each detection
or separation method has different resolution, sensitivity and
technological limitations in identifying metabolites, and it is
2 | Cambiaghi et al.
 at U
niversita degli Studi di M
ilano on N
ovem
ber 15, 2016
http://bib.oxfordjournals.org/
D
ow
nloaded from
 
T
ab
le
1.
Fe
at
u
re
s
o
f
th
e
cu
rr
en
tl
y
av
ai
la
bl
e
m
et
ab
o
lo
m
ic
d
at
a
an
al
ys
is
to
o
ls
m
o
st
ci
te
d
in
th
e
li
te
ra
tu
re
,o
rd
er
ed
by
th
ei
r
ye
ar
o
f
p
u
bl
ic
at
io
n
T
o
o
ln
am
e
T
o
o
ld
es
cr
ip
ti
o
n
D
at
a
p
re
p
ro
ce
ss
in
g
O
m
ic
s
d
at
a
in
te
gr
at
ed
an
al
ys
is
Pa
th
w
ay
an
al
ys
is
T
ra
n
sc
ri
p
to
m
ic
d
at
a
Pr
o
te
o
m
ic
d
at
a
M
et
ab
o
lo
m
ic
d
at
a
Y
ea
r
R
ef
er
en
ce
IP
A
a
A
n
al
ys
is
an
d
vi
su
al
iz
at
io
n
o
f
d
if
fe
re
n
t
ki
n
d
s
o
f
o
m
ic
s
d
at
a





N
/A
[2
8]
M
et
aC
o
re
a
Fu
n
ct
io
n
al
an
al
ys
is
an
d
vi
su
al
iz
at
io
n
o
f
d
if
fe
re
n
t
ki
n
d
s
o
f
h
ig
h
-t
h
ro
u
gh
p
u
t
o
m
ic
s
d
at
a
o





20
04
[2
4]
Pa
V
ES
y
D
at
a
m
an
ag
in
g
sy
st
em
fo
r
ed
it
in
g
an
d
vi
su
al
iz
at
io
n
o
f
bi
o
lo
gi
ca
lp
at
h
w
ay
s
o
o
o
20
04
[2
9]
Pr
o
te
o
m
e
So
ft
w
ar
ea
Q
u
an
ti
za
ti
o
n
,c
o
m
p
o
u
n
d
id
en
ti
fi
ca
ti
o
n
an
d
st
at
is
ti
ca
la
n
d
p
at
h
w
ay
an
al
ys
is




20
05
[3
0]
V
is
A
N
T
V
is
u
al
iz
at
io
n
an
d
an
al
ys
is
o
f
m
an
y
ty
p
es
o
f
bi
o
lo
gi
ca
ln
et
w
o
rk
s
o

o
o
20
05
[3
1]
V
A
N
T
ED
V
is
u
al
iz
at
io
n
an
d
an
al
ys
is
o
f
n
et
w
o
rk
s
w
it
h
re
la
te
d
ex
p
er
im
en
ta
ld
at
a




20
06
[3
2]
M
as
sT
R
IX
A
n
n
o
ta
ti
o
n
o
f
in
p
u
t
m
as
s
p
ea
ks
an
d
m
ap
-
p
in
g
o
f
th
e
id
en
ti
fi
ed
co
m
p
o
u
n
d
s
o
n
to
th
e
sp
ec
ifi
c
m
et
ab
o
li
c
p
at
h
w
ay



20
08
[3
3]
Pr
o
M
eT
ra
V
is
u
al
iz
at
io
n
an
d
in
te
gr
at
io
n
o
f
d
at
a
se
ts
o
f
d
if
fe
re
n
t
ki
n
d
s
o
f
o
m
ic
s
d
at
a
o
n
u
se
r-
d
efi
n
ed
m
et
ab
o
li
c
p
at
h
w
ay
m
ap
s
o



20
09
[3
4]
M
et
ab
o
A
n
al
ys
t
C
o
m
p
re
h
en
si
ve
m
et
ab
o
lo
m
ic
d
at
a
an
a-
ly
si
s,
vi
su
al
iz
at
io
n
an
d
in
te
rp
re
ta
ti
o
n




20
09
[2
5,
35
]
Pa
in
to
m
ic
s
In
te
gr
at
ed
vi
su
al
an
al
ys
is
o
f
tr
an
sc
ri
p
-
to
m
ic
an
d
m
et
ab
o
lo
m
ic
d
at
a
o



20
10
[3
6]
M
et
Pa
Pa
th
w
ay
an
al
ys
is
an
d
vi
su
al
iz
at
io
n
fo
r
m
et
ab
o
lo
m
ic
d
at
a
o


20
10
[3
7]
IM
Pa
La
Jo
in
t
p
at
h
w
ay
an
al
ys
is
o
f
tr
an
sc
ri
p
to
m
ic
o
r
p
ro
te
o
m
ic
an
d
m
et
ab
o
lo
m
ic
d
at
a
o




20
11
[3
8]
In
C
ro
M
A
P
Si
n
gl
e
d
at
a
se
t
an
d
in
te
gr
at
ed
cr
o
ss
-p
la
t-
fo
rm
en
ri
ch
m
en
t
an
al
ys
is
,a
n
d
p
at
h
-
w
ay
-b
as
ed
vi
su
al
iz
at
io
n
s
o
f
o
m
ic
s
d
at
a





20
11
[2
6,
39
]
3O
m
ic
s
A
n
al
ys
is
,i
n
te
gr
at
io
n
an
d
vi
su
al
iz
at
io
n
o
f
d
if
fe
re
n
t
ki
n
d
s
o
f
h
u
m
an
o
m
ic
s
d
at
a
o





20
13
[2
7,
40
]
a
In
ge
n
u
it
y
Pa
th
w
ay
A
n
al
ys
is
:C
o
m
m
er
ci
al
to
o
l.
T
ic
ks
in
d
ic
at
e
fu
ll
fu
n
ct
io
n
al
it
y;
em
p
ty
ci
rc
le
s
in
d
ic
at
e
p
ar
ti
al
fu
n
ct
io
n
al
it
y.
Analysis of metabolomic data | 3
 at U
niversita degli Studi di M
ilano on N
ovem
ber 15, 2016
http://bib.oxfordjournals.org/
D
ow
nloaded from
 
Figure 1. Flowchart of a typical metabolomic study. After sample preparation, specific metabolic signals are acquired using heterogeneous analytical platforms (DATA
ACQUISITION). Raw signals are then pre-processed to produce data in a suitable format for univariate and multivariate statistical analyses. For untargeted studies, me-
tabolites have first to be identified from spectral information (DATA PROCESSING). Significantly expressed metabolites are then linked to the biological context,
through enrichment and pathway analysis, and mapped into networks. Finally, metabolomic data are integrated with other ‘omics’ data and with prior knowledge to
gain a comprehensive view of the molecular processes involved (DATA INTERPRETATION AND INTEGRATION).
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chosen in accordance to the chemical and physical characteris-
tic of each sample and to the kind of analysis to be performed
(targeted or untargeted) [12, 15, 18]. MS is the most widely applied
technique, as it allows reliable metabolite identification, par-
ticularly when used in tandem with chromatographic separ-
ation methods so as to enhance its mass-resolving capabilities.
It is rapid (the analysis time ranges from 5 to 140 min) and
allows performing sensitive and selective qualitative and quan-
titative analyses. The main drawbacks of the MS technique are
the need to separate or purify the sample before it is directed
into the mass analyzer, and the high cost of the instrument.
Compared with MS, NMR has a lower sensitivity, thus resulting
in limited ability for metabolite identification and quantifica-
tion. This implies that potentially important compounds that
are present at smaller concentrations can be hidden by larger
peaks, and are thus less likely to be identified. The advantages
of NMR are the high analytical reproducibility and that it is a
non-destructive method that requires minimal sample prepar-
ation [43, 44].
Data processing
Once acquired, raw signals (chromatograms, spectra or NMR
data) are pre-processed by ad hoc software tools to facilitate
compound quantification (e.g. the commercial software
SIEVETM by Thermo Scientific [45], or some freely available
software packages such as the cloud-based platform XCMS [46]
or the open-source cross-platforms MAVEN [47] and MZmine 2
[48]). Generally, this preprocessing involves noise reduction,
retention time correction, peak detection and integration and
chromatogram alignment. Finally, for untargeted metabolomic
studies, different databases, such as the Human Metabolome
Database (HMDB) [49] or the Metabolite and Tandem MS
Database (METLIN) [50], are used to identify the metabolites
from spectra. During data integrity checking, different input
data are then prepared to produce appropriate data matrices
for further analyses, as better detailed in the next section.
Briefly, before starting any kind of statistical analysis, data
normalization is performed to reduce systematic biases or
technical variations, and to avoid misidentification of signifi-
cant changes owing to the different orders of magnitudes of
metabolomic data. Following which, significant differences be-
tween sample sets can be identified using appropriate statis-
tical methods. A typical statistical analysis for metabolomic
data consists of two phases: initially, different univariate and
multivariate methods are used to generate an overview of the
considered data sets and to identify the metabolites that show
significant changes under the studied conditions; then, data
mining techniques are used to discriminate groups of func-
tionally related metabolites [16]. A limit of traditional statis-
tical methods is that they highlight relationships among
variables based only on mathematical criteria (e.g. maximiza-
tion of variance or correlation), and they do not take into ac-
count correlations from biological origin [17]. For this reason,
the combined use of several statistical and data mining tech-
niques is highly recommended [4]. Once identified, signifi-
cantly expressed metabolites are first ranked using
appropriate P-values; then, a cut-off threshold is applied to se-
lect the top-k ones from the ranked list. The choice of this
threshold, which is often arbitrary, is critical, as it may influ-
ence the final biological interpretation. In fact, some moder-
ate, but significant, changes may be missed, or critical
components of a particular biological process may be left out,
thus compromising subsequent analyses [42].
Data interpretation and integration
In this last step, the selected metabolites are linked to the biolo-
gical context under study, through enrichment and pathway
analyses. More precisely, enrichment analysis aims to investi-
gate the enrichment (i.e. over- and/or under-expression) of pre-
defined groups of functionally related metabolites (i.e.
metabolite sets) to identify significant and coordinated expres-
sion changes among them. This allows taking advantage of the
list of altered metabolites to suggest a biological pathway, or
disease condition, which can be further investigated [42].
Conversely, pathway analysis involves the description and visu-
alization of the interactions among genes, proteins or metabol-
ites within cells, tissues or organs. Its goal is to identify the
pathways that significantly impact on a given biological process
[37]. Enrichment and pathway analyses are performed using ad
hoc software tools [37], which map significant metabolites to
known biochemical pathways on the basis of the information
contained in public databases such as the Kyoto Encyclopedia
of Genes and Genomes (KEGG) [8]. Once the metabolic pathways
are identified, this information has to be integrated with tran-
scriptomic and proteomic data to obtain a comprehensive view
of all the biological processes involved [22]. To capture all the
interactions that these data describe, network-based visualiza-
tion tools are commonly used by investigators to better under-
stand and show their findings. Depending on the kind of
interaction under study, a biological network can be repre-
sented through a different type of graph. Graphs are mathemat-
ical structures of several kinds, such as directed or undirected
graphs, directed acyclic graphs, trees, forests, minimum span-
ning trees, Boolean networks and Steiner trees [51]. To make
graph layouts informative and reproducible, several visualiza-
tion strategies have been proposed and adopted. A frequently
used visualization method is the ball-and-stick diagram, where
pathway data are presented as networks, with compounds (e.g.,
metabolites, proteins) as nodes and reactions as edges [23, 37,
52]. Nodes can be placed hierarchically (a father node with one
or more child nodes) or radially as in radial networks or hive
plots, which more closely represent the complexity of biological
systems [53]. To reach a more reliable evaluation of the process
under study, integration with biological knowledge derived
from the literature or from previous experimental data can also
be performed [12, 17]. In spite of the availability of this informa-
tion, effective data integration is still far to be achieved owing to
the heterogeneity of current databases. As a consequence, users
have to take into account multiple databases to extract and
manually assemble the several different information needed;
this makes data integration time-consuming, and the final in-
terpretation is often prone to errors because of different back-
ground knowledge or biases of individual researchers [42].
Software tools for metabolomic data analysis
and integration
Powerful software tools are essential to address the vast
amount and variety of data generated by metabolomic analyses.
Required software capabilities include (i) processing of raw
spectral data; (ii) statistical analysis to find significantly ex-
pressed metabolites; (iii) connection to metabolite databases for
metabolite identification; (iv) integration and analysis of mul-
tiple heterogeneous ‘omics’ data; and (v) bioinformatics ana-
lysis and visualization of molecular interaction networks [16,
18]. In this section, we introduce the four data analysis tools se-
lected (i.e. MetaCoreTM, MetaboAnalyst, InCroMAP and 3Omics);
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their main functionalities are illustrated and compared on the
basis of some selected features, such as data preprocessing
techniques used, statistical analyses performed and methods
used for functional interpretation and, if available, for data inte-
gration. The main features of each tool are summarized in
Table 2. It is important to point out that only MetaboAnalyst
provides a comprehensive module for data preprocessing and
statistical analysis [25, 41]. MetaCoreTM and 3Omics only offer
limited support for these functionalities, whereas InCroMAP
only accepts already preprocessed data. In spite of these limita-
tions, we decided to include MetaCoreTM, 3Omics and InCroMAP
in this review because of their ability to perform comprehensive
analyses of multi-omics data, which are currently limited in
other high-level analysis tools.
MetaCoreTM
MetaCoreTM [24] is a commercial tool available both as a stand-
alone and as a Web-based application. It is a software suite for
functional analysis of different kinds of high-throughput mo-
lecular data (e.g. next-generation sequencing, siRNA,
microRNA, microarray-based gene expression and serial ana-
lysis of gene expression data, array-comparative genomic-
hybridization, DNA arrays, proteomic data, metabolic profiles
and screening data). MetaCoreTM is an integrated system, which
consists of (i) a high-quality, manually curated database of
mammalian biology, including metabolites and other molecular
classes, bioactive molecules and their interactions, signaling
and metabolic pathways; (ii) genomic analysis tools to identify
potentially significant variants; (iii) a data mining toolkit for
data visualization, analysis and exchange of data; (iv) a toolkit
(pathway editor) for custom assembly of functional networks;
and (v) a set of parsers to upload and manipulate different types
of high-throughput molecular data [54–56]. Unfortunately, no
public information is available about the details of how
MetaCoreTM works; thus, our review of this tool is partially lim-
ited and some details remain unclear.
MetaboAnalyst
MetaboAnalyst [25, 35] is an integrated freely accessible Web-
based platform. It was first released in 2009, then upgraded in
2012 (MetaboAnalyst 2.0 [57]) and in 2015 (MetaboAnalyst 3.0,
also available for download and local installation). It offers a set
of online tools for metabolomic data analysis that combine stat-
istical analysis of data with their functional and biological inter-
pretation and visualization [25]; tutorials and protocol
papers are also available online. MetaboAnalyst 3.0 has been re-
implemented to improve performance, capability and user
interactivity. It offers eight functional modules, which can be
grouped in three categories: (i) exploratory statistical analysis
(Statistical Analysis and Time-Series Analysis modules); (ii) func-
tional analysis (Enrichment Analysis, Pathway Analysis and
Integrated Pathway Analysis modules for both genes and metabol-
ites); and (iii) advanced methods for translational studies
(Biomarker Analysis, Sample Size Estimation and Power Analysis
modules). In addition, it has also an Other Utilities module con-
taining a specialized function for lipidomic data analysis and a
compound ID-conversion tool [41].
InCroMAP
InCroMAP is a stand-alone Java software originally developed in
2011 for enrichment analysis and pathway-based visualizations
of genomic and proteomic data [27, 40]. The extended version
InCroMAP 1.5, released in 2013, also supports annotated metab-
olomic data, thus making this tool suitable for comprehensive
system biology studies [58]. InCroMAP is freely available at its
Web site [39], which includes a user guide [59], example data
files to test the tool and a short video tutorial. The software per-
forms metabolite set enrichment analysis and generates inter-
active global maps of the cellular metabolism. These maps
allow an integrated pathway-based visualization of data from
multiple ‘omics’ platforms and provide a useful overview of the
metabolic changes present in the studied experimental condi-
tion [26, 59].
3Omics
3Omics is a platform-independent, Web-based tool developed
in 2013 for the analysis, integration and visualization of tran-
scriptomic, proteomic and metabolomic human data. It is freely
accessible at [40], and the Web site also includes a help section.
To demonstrate the software functionalities applied to real
data, two case studies are also reported and explained in [27].
3Omics supports correlation analysis, co-expression profiling,
phenotype mapping, pathway enrichment analysis and gene
ontology-based enrichment analysis. More precisely, depending
on the data provided, the software offers four types of ‘omics’
analyses: (i) Transcriptomics–Proteomics–Metabolomics (T–P–
M), (ii) Transcriptomics–Proteomics (T–P), (iii) Proteomics–
Metabolomics (P–M) and (iv) Transcriptomics–Metabolomics
(T–M). A single-omics mode is also available to reveal intra-
omics relationships. 3Omics can also supplement missing tran-
script, protein and metabolite information related to the input
data, by text-mining the biomedical literature through iHOP (in-
formation Hyperlinked Over Protein, [60, 61]). Users can thus
perform multi-omics analyses even when only one or two out
of three ‘omics’ data sets are available [27].
Evaluation and comparison of software
functionalities
In this section, strong and weak aspects of each of the four se-
lected tools are reviewed and comparatively evaluated, follow-
ing the data analysis workflow previously described (Figure 1).
Input data
Various proprietary data formats have been developed to han-
dle and store MS or NMR raw data; this heterogeneity makes it
difficult for researchers to manipulate these data. For this rea-
son, several software for the conversion of raw data file types
(e.g. .RAW) into a universal format (e.g. .CSV, .TXT, .mzXML or
.MGF) have been implemented, such as ProteoWizard [62],
MassMatrix [63] and several others, including MATLAB [64] and
R [65, 66]. Once raw data have been converted to a suitable for-
mat, they can be further analyzed. Data types and formats
accepted as input by the four reviewed tools are reported in
Table 2. Input data are usually organized as data matrices with
samples as rows and signal features as columns. MetaCoreTM,
MetaboAnalyst and IncroMAP accept data in different kinds
of tabular format (e.g. textual tab-delimited TXT or comma-
separated value CSV files), whereas 3Omics only accepts CSV
files. MetaboAnalyst also accepts zipped files of NMR or MS
peak lists or of MS spectra, which must be in mzXML, mzDATA
or NetCDF format. As for MetaCoreTM, gene lists can also be im-
ported from output files of microarray analysis software such as
Affymetrix [67] or Agilent [68]. Compound names or IDs,
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together with the values of a numeric attribute (e.g. fold-
changes, P-values, gene expression changes, protein levels, me-
tabolite concentrations), have to be included, and the data type
has to be specified by the user [58, 69].
Data preparation
Data preparation includes integrity checking, normalization
and compound name identification. This set of procedures is
fully available only in MetaboAnalyst. MetaCoreTM and 3Omisc
just offer a tool for compound name standardization, but
MetaCoreTM also allows the integration with specific software
for data preprocessing. InCroMAP and 3Omics only accept data
already preprocessed and normalized with appropriate software
(e.g. OpenMS, MayDay, R, IBM-SPSS Statistics, SAS or JMP) [27,
58]. A brief description of each data preparation step is given in
the following text.
Data integrity checking
Among the four tools reviewed, data integrity checking is per-
formed only by MetaboAnalyst, even if other software provide
this functionality (e.g. XCMS [46] for metabolomic data or
Progenesis QI [70] for proteomic data). As for MetaboAnalyst,
this step includes handling of missing values as well as identifi-
cation and removal of outliers [69]. Missing values are automat-
ically replaced with small ones, i.e. half of the minimum
positive value in the original data, but the user can also specify
other missing value estimation methods, e.g. by replacing
them with the mean/median of the original data, or by using
K-nearest neighbors, probabilistic principal component ana-
lysis, Bayesian PCA or singular value decomposition methods.
Data normalization
MetaboAnalyst provides different normalization methods (e.g.
by sum, median or reference sample) that can be selected by the
user; data transformation (log or cube root) and scaling (auto,
pareto or range scaling) are also available [69].
Compound name identification
As there is no universally accepted set of compound labels, mol-
ecule labels in user’s input data have to be converted to identi-
fiers in public databases (e.g. HMDB, PubChem Compound,
ChEBI, KEGG or METLIN). MetaboAnalyst and 3Omics provide a
module specifically designed for this purpose [27, 41], whereas
MetaCoreTM has a built-in synonym dictionary for gene and pro-
tein names that enables compound label standardization [54].
InCroMAP does not provide an ID-conversion tool, as it only ac-
cepts data with an appropriate identifier (e.g. Affymetrix or
Agilent for genes; KEEG, HMDB or PubChem for metabolites)
[58]. We highlight that the conversion of a compound name into
its correct ID code is not a painless procedure, and can be an
additional source of error or ambiguity. Furthermore, different
results may be obtained depending on the used platform/tool.
In fact, the same compound could be associated with different
IDs according to its different molecular structures (e.g. chirality).
We recall an example reported by Cavill et al. [22] regarding the
case of lactate and KEGG identifiers: there are three KEGG iden-
tifiers that relate to lactate according to the chirality of the mol-
ecule (i.e. non-superposabity on its mirror image), and whether
these chiral metabolites are distinguishable depends on the
resolution provided by the analytical platform used. Because
they have the same mass, a solution could be using specifically
selected elution columns in MS to ensure they elute at different
times and are thus experimentally distinguishable.
Statistical analysis
Out of the four tools reviewed, MetaboAnalyst is the one that
offers the most complete set of statistical and machine learning
methods for data analysis. 3Omics only performs clustering and
co-expression analysis, whereas InCroMAP does not provide a
statistical module. Unfortunately, only limited information is
available about the data analysis performed by MetaCoreTM, but
it seems incorporated in the pathway analysis module. Analysis
algorithms used in MetaboAnalyst and 3Omics have originally
been implemented in the R open-source project [65, 66].
A wide variety of statistical methods and data mining
approaches can be applied on metabolomic data depending on
the kind of experiment performed. In the following text, we il-
lustrate both univariate and multivariate statistics and also
briefly describe time-course analysis for completeness.
Univariate analysis
It is usually the first analysis performed, as it provides a prelim-
inary overview about the data features that are potentially sig-
nificant in discriminating the conditions under study. 3Omics
performs co-expression analysis by means of an algorithm that
computes dissimilarity coefficients using the Euclidean dis-
tance, and displays results as heat maps.
For two-group data, MetaboAnalyst provides fold change
analysis, t-test and volcano plots (i.e. a type of scatter plots to
quickly identify changes in large data sets of replicate data, hav-
ing the fold change on the x-axis and the negative log of the
P-value on the y-axis), both for unpaired and paired analyses.
For multi-group data, it provides one-way analysis of variance
(ANOVA), with associated post hoc analyses, and correlation
analysis. As a large number of metabolites are usually present
for each patient or biological sample, and an individual statis-
tical test has to be performed for each metabolite, a high num-
ber of false-positive results can be obtained owing to multiple
testing. To limit it, a multiple testing correction technique (e.g.
Bonferroni, Bonferroni–Holm, Westfall–Young or Benjamini–
Hochberg correction) must be used to adjust the obtained sig-
nificance P-values to keep the probability of observing at least
one significant result owing to chance below a predetermined
level [71]. The Benjamini–Hochberg correction [72], also known
as false discovery rate (FDR), is the recommended one, as it
allows controlling the proportion of false positives among all
significant results. Both FDR- and Bonferroni-corrected P-values
are provided by MetaboAnalyst for each evaluated metabolite.
Multivariate analysis
It involves the simultaneous observation and analysis of more
than two statistical variables. It is ideal for the analysis of
‘omics’ data, as they usually consist of several features that
change as a function of time, phenotype or experimental condi-
tion. Multivariate analysis techniques include multivariate
ANOVA, multivariate regression analysis, factor analysis, prin-
cipal component analysis and partial least square discriminant
analysis; all of them are supported by MetaboAnalyst. These
techniques are useful for exploratory data analysis, as they
allow summarizing original variables in fewer variables using
their weighted average.
Clustering
Cluster analysis aims to determine intrinsic groups in a set of
unlabeled data; thus, it is useful to identify groups of metabol-
ites that have similar characteristic or behavior, or that belong
to the same biological pathway. MetaboAnalyst supports two
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types of clustering: hierarchical clustering (with results visual-
ized through heat maps and dendrograms) and partitional clus-
tering (using K-means or self-organizing map algorithm),
whereas 3Omics only performs hierarchical clustering.
Classification
On the basis of a training set, it allows to identify to which cat-
egory a new sample belongs, and to assign metabolites to a
known group or pathway in high-dimensional data.
Classification methods supported by MetaboAnalyst are ran-
dom forest and support vector machines.
Time-course analysis
Provided only by MetaboAnalyst, it allows detecting trends in
metabolite concentrations or metabolite distribution patterns
over time, e.g. to study treatment effects during multiple time
points. The MetaboAnalyst module currently supports both
multivariate empirical Bayes time-series analysis for detecting
distinctive temporal profiles across different experimental con-
ditions and ANOVA-simultaneous component analysis (ASCA)
for the identification of major patterns associated with each ex-
perimental factor and their interactions [41, 57].
Data interpretation and integration
This final step of the data analysis workflow allows linking sig-
nificantly expressed metabolites to the biological context under
investigation. As shown in Figure 1, this step consists of three
parts (i.e. functional interpretation, metabolite mapping and data in-
tegration), described in the following text.
Functional interpretation
It includes enrichment analysis and pathway analysis. These
two approaches often overlap (pathway–enrichment analysis),
as both work by comparing significant metabolites, identified
by the statistical analyses, to predefined functional groups
derived from previous knowledge.
MetaCoreTM contains many options for enrichment and
pathway analyses, some of which are specifically designed for
drug discovery and disease investigation. By default, calcula-
tions are set to compare the user’s data set to the entire soft-
ware database; in the case of a limited data set, a specific
restricted list of compounds can be selected from the entire
MetaCoreTM database and used for comparison (data filtration).
The statistics performed is based on the hypergeometric mean,
and returns a P-value that ranks the intersection between the
uploaded data and the content prebuilt in MataCoreTM. Results
are displayed as histograms, with pathways ordered from the
most to the least significant one [55, 56].
MetaboAnalyst incorporates the Metabolite Set Enrichment
Analysis (MSEA) and Metabolomics Pathway Analysis (MetPA)
software for metabolite set enrichment analysis and pathway
analysis, respectively [17, 42]. MSEA offers three different kinds
of enrichment analyses, i.e. over-representation analysis (ORA),
single sample profiling (SSP) and quantitative enrichment ana-
lysis (QEA); a description of these methods can be found in [42,
69]. Briefly, ORA evaluates if a particular set of metabolites is
represented more than expected in a given compound list ex-
tracted from a single biological sample; SSP allows to investi-
gate if certain metabolite concentrations in a given sample are
higher or lower than their normal range; QEA is similar to ORA,
but used with multiple samples (e.g. collected at different time
points or belonging to different patients) [42]. All these three
methods generate graphs or tables with embedded hyperlinks
to relevant pathway images and disease descriptions. MetPA
provides several different algorithms for pathway analysis,
including Fisher’s exact test, hypergeometric text, global test
and GlobalAncova [37]. Compound importance in the given
metabolic pathway is estimated through its betweenness cen-
trality and out-degree centrality (refer to [37, 69] for further de-
tails). Results are presented in two parts: a table with all
analysis results and the graphical output, which contains
three view levels: metabolome view, pathway view and compound
view. The metabolome view and a pathway view are shown in
Figure 2. Some graphical visualization features of MetaboAnalyst: metabolome view (A) and pathway view (B). Images were obtained using the example data provided
with the MetaboAnalyst software. In the metabolome view, each circle represents a different pathway; circle size and color shade are based on the pathway impact
and p-value (red being the most significant), respectively. By clicking on a circle, the corresponding pathway view is generated, showing all genes involved in that path-
way and their interactions. The codes represent compound IDs as reported in KEGG. In (B), the taurine and hypotaurine metabolism pathway is shown. As for compound
colors within the pathway view, light blue means the metabolite is not in the uploaded data, but it has been used as background for enrichment analysis, whereas
other colors (varying from yellow to red) mean the metabolite is in the data, with a different level of significance (red being the most significant). A colour version of
this figure is available at BIB online: http://bib.oxfordjournals.org.
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Figure 2. Pathway and compound views are generated dynamic-
ally, based on the user’s interaction with the visualization sys-
tem; usually, multiple pathway and compound views can be
obtained from a metabolome view.
InCroMAp performs both single data set and integrated
cross-platform enrichment and pathway analyses, using data
from individual or heterogeneous platforms. In the former, sin-
gle-platform case, a hypergeometric test is used to detect rele-
vant pathways, whereas a straightforward extension of the
single-platform method is used in the latter case. Unidentified
metabolomic features, i.e. which cannot be mapped to a known
set of genes, proteins or metabolites, are automatically dis-
carded. Results are presented in a table or a barplot, sorted ac-
cording to the associated P-values [58].
3Omics provides enrichment and pathway analyses for T–P–
M, P–M, T–M and single metabolomic data. To perform the ana-
lysis, the user has to select a known metabolite set and one
obtained from experimental data. Significantly enriched path-
ways are identified with a hypergeometric test. Results are re-
ported in tables, ranked according to their probability.
Metabolites in the pathways are displayed alongside hyperlinks
to the HMDB or HumanCyc database [27].
Metabolite mapping and data visualization
Metabolites are mapped to their biological pathway as networks
of interconnected nodes, thus transforming the original un-
structured data into logically structured and visually under-
standable representations [73]. In this way, users can more
easily identify relationships and hidden patterns among the
data, which facilitates hypothesis generation and result
interpretation.
MetaboAnalyst does not require this step, as it already pro-
vides interactive Google-Maps-style graphs of pathways and
metabolites for the visualization of enrichment and pathway
analysis results.
Within MetaCoreTM, biological networks are built on input
metabolite lists after metabolite preselection through enrich-
ment and pathway analyses. According to the aim of the study
and the data set size, users can choose among several network-
building algorithms, which are described in details in [54, 55].
Networks are generated as a combination of single-step inter-
actions (directed edges) connecting metabolites, proteins or
genes (nodes). Each node is associated with a specific com-
pound through the MetaCoreTM database architecture, and
users can retrieve the information about the node-associated
compound simply by clicking on the node. An info page opens,
containing many links with information about the node-
associated object (e.g. gene, protein, metabolite, ligand, tran-
scription factor or enzyme), maps where the object appears,
related gene ontology processes or diseases, all known drugs for
the object and a list of the object’s network interactions.
Significant expression or abundance changes of specific com-
pounds are also visually shown as a red or blue solid circle
above the node, indicating increased or decreased expression/
abundance, respectively (Figure 3).
InCroMAP provides metabolite mapping support through
two different kinds of data visualizations: the integrated visual-
ization and the global metabolic overview. The integrated visual-
ization overlays a selected pathway of interest with the
corresponding ‘omics’ experimental data; the global metabolic
view integrates multi-omics data and displays them in a single
graph where each subordinate metabolic pathway is colored ac-
cording to the significance of its enrichment [58].
3Omics generates compound networks through the
Correlation Network module, which incorporates the ‘cor’ func-
tion from R to compute the Pearson’s correlation coefficient
(PCC). The PCCs between each pair of interconnected elements
in the network are calculated from two sets of values, which
can be of the same kind (intra-‘omics’ analysis) or of different
kinds (inter-‘omics’ analysis). In the latter case, transcripts,
Figure 3. Example of a biological network representation in MetaCoreTM. According to their shape and color, nodes represent genes, proteins, metabolites or other bio-
logical elements, while directed edges represent the reactions intercurring between them: green for activation, red for inhibition and gray if unspecified. Compounds
with abundance change are identified by a red (abundance increasing i.e. ZFX) or blue (abundance decreasing i.e. TAP1, RFX5) solid circle above them. A colour version
of this figure is available at BIB online: http://bib.oxfordjournals.org.
10 | Cambiaghi et al.
 at U
niversita degli Studi di M
ilano on N
ovem
ber 15, 2016
http://bib.oxfordjournals.org/
D
ow
nloaded from
 
proteins and metabolites are all represented in the same graph
and identified with different symbols (squares, triangles and
circles, respectively). Uploaded data are automatically mapped
into networks using a force-directed layout algorithm.
Literature-derived relationships are presented as dotted lines,
whereas solid lines indicate strong correlations (PCC> 0.9) iden-
tified between the uploaded data [27].
Data integration
It is crucial to obtain meaningful biological insights, but it is still
difficult to achieve. Currently, high-throughput analysis tools
mainly perform data integration through network building;
thus, they provide a ‘visual integration’ of the different kinds of
‘omics’ data, whereas the interpretation is left to the users. In
light of these considerations, for MetaCoreTM, InCroMAP and
3Omics, we can consider data integration as part of metabolite
mapping, as they map all ‘omics’ data levels on the same net-
work. MetaboAnalyst instead provides a specific module for
integrated pathway analysis, which enables users to integrate
data from gene expression and metabolomic experiments.
Users have to upload a list of genes and metabolites of interest,
identified from the same samples or obtained under similar ex-
perimental conditions; genes and metabolites are then mapped
to KEGG pathways for overrepresentation analysis. In spite of
its great usefulness, this MetaboAnalyst module still has some
limitations. On the positive side, by combining the evidence
based on changes in both gene expressions and metabolite con-
centrations, it is more likely to identify which pathways are
involved or up-/down-regulated in a biological process. On the
negative side, users have to keep in mind that these graphical
representations are prone to errors. In fact, although the entire
transcriptome is routinely mapped, current metabolomic tech-
nologies capture only a small portion of the metabolome; this
difference can thus lead to potentially biased results. Moreover,
this module does not support proteomic data; thus, a compre-
hensive multilevel data integration cannot be achieved yet [41].
Output data
Once the data analysis, integration and interpretation have
been performed, users can export the results in different for-
mats, to use them for further analysis.
MetaCoreTM allows saving networks in two formats: Network
and Netshot. Netshot saves the network exactly as it is, whereas
Network does not retain the expression data and will reflect any
subsequent changes to the objects or interactions in the net-
work as the MetaCoreTM database is updated. Thereby, saving a
network in both formats enables users to see exactly how it
looked when it was created (Netshot) and how it may have
changed after subsequent MetaCoreTM updates (Network). High-
quality images of networks and maps can be saved in PNG for-
mat. MetaCoreTM also provides a Data Sharing module to share
experiments, gene lists and saved networks with other users or
groups, with different permission levels [55].
MetaboAnalyst generates a report in a PDF format contain-
ing plots, graphs and tables with all the results of the analyses
performed and a brief explanation; plots, graphs and tables can
also be downloaded as TIF files. In addition, the processed nu-
meric data, high-resolution images (PNG format), R scripts and
R command history are also available for downloading (before
being deleted, raw data files are stored on the server for 72 h).
Users can easily rerun, and, in some cases, modify, resulting R
scripts on their local machine after installation of the R software
and the required packages [25, 66]. As for InCroMAP, the results
of the enrichment analysis can be exported in a tabular format
(e.g. CSV), and the pathway-based visualization can be stored as
a JPG file. In 3Omics, network images can be exported in PNG,
SVG or SIF formats, and all processed data can be downloaded
for further analyses. To safeguard data confidentiality, up-
loaded data files are only temporarily stored during their evalu-
ation section and then deleted after processing.
Conclusion
The fast-growing metabolomics domain generates high quanti-
ties of valuable data that require integration and comprehen-
sive analysis with other ‘omics’ data to be fully interpreted. The
most common approach consists in simultaneously monitoring
the levels of transcripts, proteins and metabolites, and in com-
bining the obtained data to infer the structure and dynamics of
the underlining biological networks in data sets of interest.
Several statistical and computational methods are required to
analyze and integrate this diverse and large amount of data;
computational tools supporting also data visualization and me-
tabolite mapping greatly help to quickly identify the relevant
metabolites and the involved biological processes in the studied
conditions.
Of the many tools available for processing and analyzing
metabolomic data, we reviewed and compared four of the most
relevant for number of users or provided features, and pointed
out their advantages and drawbacks. MetaCoreTM is the one with
the wider integrated database of molecular information, contain-
ing more than 1500 signaling and metabolic pathway maps and
over 1.3 million molecular interactions, which is continually
updated to guarantee reliability and comprehensiveness [45].
This makes MetaCoreTM a powerful tool for researchers in many
different fields, from drug discovery to biomarker identification
and clinical applications. It also provides several biological net-
work-building algorithms to map high-throughput experimental
data into interactive and information-rich networks. The great
limitation in the use of this software is that it requires purchas-
ing a license, whose cost not all research groups can afford.
Among the freely available tools, MetaboAnalyst is the most
complete one, as it offers comprehensive data processing op-
tions, a wide array of univariate and multivariate statistical
methods and extensive data visualization and functional ana-
lysis modules. Its main limitation is the lack of support for
proteomic data integration. Given its high ease of use, InCroMAP
addresses to investigators of any kind of discipline, and it is suit-
able for the evaluation of system biology studies. However, its
lack of a data preprocessing module requires the use of other
software to prepare the input data. 3Omics is useful for re-
searchers interested in integrated visualization and one-click
comparative analysis of multiple ‘omics’ data in a simple and
rapid way. Yet, as InCroMAP, it does not support data prepro-
cessing, and it provides only a few statistical methods for data
analysis; furthermore, it only supports human data evaluations.
Overall, in spite of the undeniable validity of the tools re-
viewed, there are still several challenges that need to be ad-
dressed, mainly in the field of data integration, to support a
thorough comprehensive evaluation of the experimental data
and a deeper understanding of the biological processes.
Although multiple ‘omics’ data are increasingly available, an
open issue is still their effective use to understand the biological
mechanisms responsible for the variance in the observed
metabolomic profiles. Toward this goal, further development
and improvement of computational techniques for efficient
storage, integration and use of prior knowledge, identification
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and accurate quantification of metabolites, heterogeneous
‘omics’ data integration and pathway visualization are essential
and shall continue to be the focus of the bioinformatics commu-
nity in the next future.
Key Points
• Metabolomics is a growing field of biology that gener-
ates large amounts of data; handling, processing and
analysis of these data are still challenging and require
specialized mathematical, statistical and bioinfor-
matics tools.
• Metabolomic data alone are not enough to gain thor-
ough understanding of a biological system and its be-
havior under pathological conditions; integration with
other ‘omics’ data (mainly transcriptomics and prote-
omics) and with previous knowledge is needed to gain
deeper knowledge.
• Several tools are available for ‘omics’ data analysis
and integration, which constitute an invaluable help
for researchers in many different fields; in spite of
this, there are still open challenges, mainly regarding
heterogeneous data integration and their comprehen-
sive analysis, that need to be faced to take effective
advantage of new experimental data and available
knowledge.
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